Diagnostics firm Avacta Group names head of research and development amid expansion into antibody market.
Avacta Group, a Leeds University spin-out specialising in diagnostic tools, has named Matt Johnson as its lead affirmer of research and development and production operations as it capitalises on its Affirmers intellectual property (IP). The firm acquired the rights to the IP in February 2012, which is an alternative to antibodies based on a robust…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
